Understanding the Type of Heart Failure

Before prescribing medication, clinicians identify the type and cause of heart failure. One important measurement is the left ventricular ejection fraction, or LVEFthe percentage of blood pumped out of the heart’s main pumping chamber with each contraction.

Heart Failure With Reduced Ejection Fraction

Heart failure with reduced ejection fraction, abbreviated HFrEF, usually means the left ventricle has weakened and cannot squeeze normally. An ejection fraction of 40% or less generally falls into this category. HFrEF has the clearest evidence for a combination of medications known as guideline-directed medical therapy.

Heart Failure With Preserved Ejection Fraction

In heart failure with preserved ejection fraction, or HFpEF, the heart’s pumping percentage may appear normal, but the muscle is stiff and does not relax or fill properly. Treatment often focuses on relieving congestion and managing contributing problems such as high blood pressure, atrial fibrillation, coronary artery disease, obesity, diabetes, kidney disease, and sleep apnea.

The Middle and Improved Categories

Heart failure with mildly reduced ejection fraction generally refers to an LVEF between 41% and 49%. Some people also develop heart failure with improved ejection fraction after treatment. Improved numbers are excellent news, but they usually do not mean medication can be stopped. Continuing effective therapy helps protect the gains already made.

The Four Foundations of HFrEF Medication

For many people with symptomatic HFrEF, treatment is built around four medication classes. They work through different biological pathways, which is precisely why clinicians often use them together. Think of them as a four-person repair crew: one worker is helpful, but the job goes better when the whole team shows up.

1. ARNI, ACE Inhibitor, or ARB Therapy

These medications reduce the harmful effects of hormonal systems that narrow blood vessels, retain sodium, and make the heart work harder.

An angiotensin receptor-neprilysin inhibitor, or ARNI, combines sacubitril and valsartan. For eligible patients with HFrEF, it can reduce cardiovascular death and heart failure hospitalization. If an ARNI is unsuitable, an angiotensin-converting enzyme inhibitor, known as an ACE inhibitor, or an angiotensin receptor blocker, known as an ARB, may be prescribed instead.

Possible problems include low blood pressure, dizziness, changes in kidney function, elevated potassium, cough with ACE inhibitors, andrarelyserious swelling called angioedema. An ARNI must not be taken at the same time as an ACE inhibitor. FDA labeling requires a 36-hour separation when switching between them because combining the drugs increases the risk of angioedema.

2. Evidence-Based Beta Blockers

Beta blockers slow the heart rate, reduce stress-hormone activity, and protect the heart from chronic overwork. The beta blockers with established HFrEF benefits are carvedilol, metoprolol succinate, and bisoprolol.

People may initially notice fatigue, lightheadedness, cold hands, or a slower pulse. These effects often improve as the body adjusts. Doses are commonly started low and increased gradually. Beta blockers are not interchangeable simply because their names sound vaguely related; the specific drug and formulation matter.

They are generally introduced or increased when the patient is medically stable. Starting or aggressively increasing a beta blocker during severe fluid overload or cardiogenic shock can be unsafe.

3. Mineralocorticoid Receptor Antagonists

Spironolactone and eplerenone are mineralocorticoid receptor antagonists, or MRAs. They limit the effects of aldosterone, a hormone that contributes to sodium retention, potassium loss, inflammation, and harmful remodeling of the heart.

MRAs can improve outcomes in appropriately selected patients with HFrEF, but they require monitoring of potassium and kidney function. Excess potassium can disturb the heart’s electrical rhythm. Potassium supplements and potassium-containing salt substitutes should not be added casuallythe heart may enjoy rhythm, but it does not appreciate improvisational jazz from its electrolytes.

Spironolactone may also cause breast tenderness or enlargement in some people. Eplerenone tends to cause fewer hormone-related effects but may cost more.

4. SGLT2 Inhibitors

Sodium-glucose cotransporter-2 inhibitors were originally developed for type 2 diabetes, but research showed that certain drugs in this class also benefit people with heart failure, including many who do not have diabetes. Dapagliflozin and empagliflozin are commonly used examples.

SGLT2 inhibitors help the kidneys release glucose and sodium into the urine and have broader effects on cardiovascular and kidney function. In heart failure, they can reduce hospitalization risk and provide benefits across a wider range of ejection fractions than many older treatments.

Possible adverse effects include genital yeast infections, increased urination, dehydration, low blood pressure, and urinary infections. A rare but serious complication is ketoacidosis, which can occur even when blood glucose is not extremely high. Patients may receive instructions to temporarily hold an SGLT2 inhibitor during prolonged fasting, major surgery, or a severe illness that limits food and fluid intake. Any such pause should follow the prescriber’s plan.

Diuretics: Relief From Fluid Overload

Diuretics, frequently called water pills, help the kidneys remove excess sodium and water. Loop diuretics such as furosemide, torsemide, and bumetanide are often prescribed when heart failure causes swollen legs, abdominal bloating, rapid fluid-related weight gain, or breathlessness.

These medicines can provide dramatic symptom relief, but they serve a different purpose from the four foundational HFrEF drug classes. Diuretics primarily control congestion; the dose may rise or fall according to fluid status. Taking too little may allow fluid to accumulate, while taking too much can cause dehydration, low blood pressure, kidney problems, or abnormal sodium, potassium, and magnesium levels.

A large NIH-supported comparison found no survival advantage of torsemide over furosemide, reinforcing the importance of choosing a practical diuretic regimen and adjusting it to the individual rather than searching for a universally superior water pill.

Additional Medications for Selected Patients

Hydralazine and Isosorbide Dinitrate

This combination widens blood vessels through complementary mechanisms. It may be recommended for certain Black patients with symptomatic HFrEF who remain symptomatic despite standard therapy. It may also be considered when an ARNI, ACE inhibitor, or ARB cannot be used. Headache, dizziness, and low blood pressure are common limitations.

Ivabradine

Ivabradine lowers the heart rate without producing the same effects as a beta blocker. It may be considered for selected people with stable symptomatic HFrEF who remain in sinus rhythm with an elevated resting heart rate despite the highest tolerated beta-blocker dose. Possible effects include a slow pulse, atrial fibrillation, and brief visual brightness.

Digoxin

Digoxin may improve symptoms and reduce hospitalization in selected patients, but it does not replace foundational therapy. Because the safe range is narrow, dosing must account for age, kidney function, body size, electrolytes, and drug interactions. Nausea, confusion, appetite loss, unusual visual changes, or a new abnormal heartbeat can signal toxicity and deserve prompt evaluation.

Vericiguat

Vericiguat may be considered for some people with high-risk HFrEF who recently experienced worsening symptoms or a hospitalization despite standard treatment. It is not a routine first medication and is generally added only after the core regimen has been reviewed and optimized.

Blood Thinners

Anticoagulants are not automatically prescribed simply because someone has heart failure. They may be needed when a separate indication exists, such as atrial fibrillation, a blood clot, a mechanical heart valve, or another condition that raises embolic risk. Unnecessary anticoagulation adds bleeding risk without providing a free cardiovascular bonus.

How Heart Failure Medication Is Safely Adjusted

Heart failure drugs are often started at low doses and adjusted over several visits. Clinicians evaluate blood pressure, heart rate, symptoms, kidney function, potassium, sodium, and fluid status. The ideal dose is not necessarily the largest dose printed in a guideline. It is the most effective dose the individual can tolerate safely.

Importantly, low doses of several complementary medications may provide broader protection than pushing one medicine to its maximum while leaving the other classes unused. Contemporary treatment strategies encourage introducing the foundational HFrEF therapies efficiently rather than spending many months perfecting one drug before discussing the next.

Patients should never stop a heart failure medicine abruptly or change a diuretic dose unless they have been given a specific adjustment plan. A home blood pressure cuff, weight scale, current medication list, and symptom record can make follow-up visits much more productive. CardioSmart and HFSA resources also encourage shared decision-making so that treatment reflects both clinical evidence and the patient’s priorities.

Medicines and Supplements That Can Cause Trouble

Over-the-counter products are not automatically heart-friendly. Nonsteroidal anti-inflammatory drugs, or NSAIDs, such as ibuprofen and naproxen can promote sodium and fluid retention, increase blood pressure, and worsen kidney function. They may also interfere with diuretics and other heart failure medications.

Some cold remedies contain decongestants that can raise heart rate or blood pressure. Effervescent products may contain surprising amounts of sodium. Potassium supplements, salt substitutes, herbal remedies, and “natural” energy products can also interact with treatment.

The safest habit is to show the pharmacist and prescriber a complete list of prescriptions, nonprescription medicines, vitamins, supplements, powders, teas, and occasional remedies. If it enters the mouth and promises to “cleanse,” “boost,” or “detox” something, it belongs on the list.

More Than Medication: Daily Heart Failure Care

Monitor Weight and Symptoms

Daily weighing can reveal fluid buildup before swelling becomes obvious. Patients are often advised to weigh themselves at the same time each morning, after using the bathroom and before breakfast, while wearing similar clothing. A commonly used warning threshold is a gain of about three pounds in one day or five pounds in a week, although every patient should follow the personalized action plan provided by the care team.

Use an Individualized Sodium and Fluid Plan

Reducing excess sodium can help limit fluid retention, but the appropriate target varies. Extremely restrictive diets are not automatically better, particularly when they reduce food intake or create nutritional problems. Fluid restriction is also not required for every person with heart failure. It is generally individualized according to symptoms, blood sodium, kidney function, and congestion.

Stay Physically Active When Medically Stable

Regular activity can improve endurance, strength, mood, and quality of life. The safe starting point may be a few supervised minutes rather than a heroic encounter with a treadmill. Cardiac rehabilitation offers monitored exercise, education, and risk-factor support for eligible patients.

Manage the Conditions Feeding the Problem

Good heart failure care also addresses high blood pressure, diabetes, coronary disease, abnormal heart rhythms, anemia or iron deficiency, kidney disease, obesity, sleep apnea, smoking, and excessive alcohol use. Treating these conditions may improve symptoms and reduce further strain on the heart.

Devices, Procedures, and Advanced Heart Failure Care

Medication is central, but it is not the entire toolbox. Some patients with persistently reduced ejection fraction may qualify for an implantable cardioverter-defibrillator, which can treat certain life-threatening rhythms. Cardiac resynchronization therapy may help selected people whose ventricles contract out of sync.

Procedures may also be needed to treat blocked coronary arteries, valve disease, congenital abnormalities, or persistent arrhythmias. People with advanced heart failure may be evaluated for a left ventricular assist device or heart transplant. Referral to a specialized heart failure team can also open discussions about symptom-focused care, caregiver support, clinical trials, and treatment goals.

Palliative care is not the same as giving up. It can be introduced alongside active heart failure treatment to address breathlessness, fatigue, anxiety, pain, difficult decisions, and family needs.

When Symptoms Need Urgent Attention

Call the heart failure care team promptly for new or worsening swelling, a rapid weight increase, more breathlessness than usual, difficulty lying flat, persistent coughing, dizziness, unusual weakness, reduced urination, or a noticeably irregular heartbeat.

Emergency medical help is appropriate for severe breathing difficulty, fainting, confusion, blue or gray lips, coughing pink or foamy mucus, sudden severe chest pressure, or symptoms suggesting a heart attack or stroke. A worsening episode is not the ideal moment to negotiate with the body by saying, “Let’s see how this looks tomorrow.”

Real-World Experiences: What Treatment Often Feels Like

The following are composite experiences based on common patterns described in heart failure education and clinical care. They are not accounts of specific identifiable patients.

The First Week Can Feel Like a Pharmacy Moved In

A newly diagnosed patient may leave the hospital with several unfamiliar bottles, a scale, dietary instructions, and follow-up appointments. The first reaction is often, “I came in because I was short of breath. Why do I now need a minor degree in pharmacology?”

A written schedule can turn the medication pile into a manageable routine. Morning medicines go beside the breakfast setup, evening medicines are linked to another daily habit, and a weekly organizer provides a quick visual check. Patients often find that using both generic and brand names on the medication list prevents confusion when labels, discharge documents, and insurance notices use different terminology.

Feeling Better Does Not Mean the Disease Has Vanished

After a diuretic removes excess fluid, breathing may improve quickly. Shoes fit again, sleep becomes easier, and the scale moves in the correct direction. That relief can create the impression that treatment has finished.

In reality, congestion control is only one part of the plan. Medications such as beta blockers, ARNIs, MRAs, and SGLT2 inhibitors may continue protecting the heart even when their effects are not immediately noticeable. Patients commonly compare this with maintaining a roof: waiting for water to pour into the living room is a poor maintenance strategy.

Medication Adjustment Is Usually a Process

One visit may produce a lower blood pressure reading. Another may show increased potassium or a small change in kidney function. The clinician may adjust one medicine, repeat laboratory tests, or ask for additional home readings. This does not necessarily mean treatment has failed. It often means the care team is looking for the safest balance among heart protection, kidney function, blood pressure, and symptom control.

Patients who bring a simple log of weight, pulse, blood pressure, dizziness, swelling, and medication timing give their clinicians useful information. “I felt strange sometime last week” is less actionable than “I became lightheaded two hours after my morning dose on three consecutive days.”

Food Habits May Require More Work Than the Pills

Many people discover that the saltshaker was not the main problem. Sodium may be hiding in deli meat, canned soup, frozen dinners, sauces, restaurant meals, breads, and packaged snacks. Reading labels can initially turn grocery shopping into an archaeological expedition.

Over time, people often build a short list of reliable meals rather than examining every product from scratch. Fresh ingredients, unsalted seasonings, lemon, vinegar, garlic, herbs, and spices can restore flavor. The goal is a sustainable pattern, not a lifetime sentence of boiled vegetables staring sadly from a beige plate.

Support Changes the Experience

Heart failure treatment is easier when someone else knows the plan. A family member may help notice swelling, organize refills, attend appointments, or recognize that unusual fatigue is more than “just a bad day.” Pharmacists can identify duplicate drugs and interactions. Nurses often help troubleshoot weight changes and side effects before they become emergencies.

The most effective experience is usually collaborative. The patient reports what is actually happening, the healthcare team listens and adjusts treatment, and both sides agree on what requires a phone call. Heart failure care may be complicated, but it becomes less intimidating when every medication has a purpose, every warning sign has an action, and every question is treated as worth asking.

Conclusion

Heart failure treatment has changed substantially. For HFrEF, a coordinated combination of an ARNI, ACE inhibitor, or ARB; an evidence-based beta blocker; an MRA; and an SGLT2 inhibitor forms the foundation for many patients. Diuretics control congestion, while additional medications, devices, procedures, rehabilitation, and advanced therapies are selected according to individual needs.

The central lesson is that heart failure care works best as a system. Medication adherence, laboratory monitoring, symptom tracking, physical activity, sodium awareness, treatment of related conditions, and early communication all reinforce one another. The regimen may look crowded, but every well-chosen component has a joband the goal is not merely to collect pill bottles. It is to help the heart work more efficiently while preserving the life happening around it.